Department of Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan; Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital
2.Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
3.Department of General Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
4.Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
5.Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan
Lupus myelitis (LM) is a rare but serious complication of systemic lupus erythematosus (SLE). In 2009, Birnbaum et al. suggested that LM could be classified into two subtypes, namely gray and white matter myelitis, based on neurological examination findings. Here we describe three cases of this disorder, one with signs of white matter dysfunction and two with signs of gray matter dysfunction. We discuss the potential role of autoantibodies in the development of LM.
.png)